» Articles » PMID: 15367681

Suppressor of Fused Regulates Gli Activity Through a Dual Binding Mechanism

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2004 Sep 16
PMID 15367681
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

The Hedgehog pathway drives proliferation and differentiation by activating the Gli/Ci family of zinc finger transcription factors. Gli/Ci proteins form Hedgehog signaling complexes with other signaling components, including the kinesin-like protein Costal-2, the serine-threonine kinase Fused, and Suppressor of Fused [Su(fu)]. In these complexes Gli/Ci proteins are regulated by cytoplasmic sequestration, phosphorylation, and proteolysis. Here we characterize structural and functional determinants of Su(fu) required for Gli regulation and show that Su(fu) contains at least two distinct domains: a highly conserved carboxy-terminal region required for binding to the amino-terminal ends of the Gli proteins and a unique amino-terminal domain that binds the carboxy-terminal tail of Gli1. While each domain is capable of binding to different Gli1 regions independently, interactions between Su(fu) and Gli1 at both sites are required for cytoplasmic tethering and repression of Gli1. Furthermore, we have solved the crystal structure of the amino-terminal domain of human Su(fu)(27-268) at 2.65 A resolution. This domain forms a concave pocket with a prominent acidic patch. Mutation at Asp(159) in the acidic patch disrupts Gli1 tethering and repression while not strongly disrupting binding, indicating that the amino-terminal domain of Su(fu) likely impacts Gli binding through a mechanism distinct from that for tethering and repression. These studies provide a structural basis for understanding the function of Su(fu).

Citing Articles

The hedgehog pathway in hematopoiesis and hematological malignancy.

Lemos T, Merchant A Front Oncol. 2022; 12:960943.

PMID: 36091167 PMC: 9453489. DOI: 10.3389/fonc.2022.960943.


ERK2 MAP kinase regulates SUFU binding by multisite phosphorylation of GLI1.

Bardwell A, Wu B, Sarin K, Waterman M, Atwood S, Bardwell L Life Sci Alliance. 2022; 5(11).

PMID: 35831023 PMC: 9279676. DOI: 10.26508/lsa.202101353.


Teaching an old dog new tricks: reactivated developmental signaling pathways regulate ABCB1 and chemoresistance in cancer.

Lee W, Frank T Cancer Drug Resist. 2022; 4(2):424-452.

PMID: 35582031 PMC: 9019277. DOI: 10.20517/cdr.2020.114.


Hedgehog/GLI Signaling Pathway: Transduction, Regulation, and Implications for Disease.

Sigafoos A, Paradise B, Fernandez-Zapico M Cancers (Basel). 2021; 13(14).

PMID: 34298625 PMC: 8304605. DOI: 10.3390/cancers13143410.


Targeting of SET/I2PP2A oncoprotein inhibits Gli1 transcription revealing a new modulator of Hedgehog signaling.

Serifi I, Besta S, Karetsou Z, Giardoglou P, Beis D, Niewiadomski P Sci Rep. 2021; 11(1):13940.

PMID: 34230583 PMC: 8260731. DOI: 10.1038/s41598-021-93440-0.


References
1.
Methot N, Basler K . Hedgehog controls limb development by regulating the activities of distinct transcriptional activator and repressor forms of Cubitus interruptus. Cell. 1999; 96(6):819-31. DOI: 10.1016/s0092-8674(00)80592-9. View

2.
Chen Y, Cardinaux J, Goodman R, Smolik S . Mutants of cubitus interruptus that are independent of PKA regulation are independent of hedgehog signaling. Development. 1999; 126(16):3607-16. DOI: 10.1242/dev.126.16.3607. View

3.
Pearse 2nd R, Collier L, Scott M, Tabin C . Vertebrate homologs of Drosophila suppressor of fused interact with the gli family of transcriptional regulators. Dev Biol. 1999; 212(2):323-36. PMC: 4530617. DOI: 10.1006/dbio.1999.9335. View

4.
Sasaki H, Nishizaki Y, Hui C, Nakafuku M, Kondoh H . Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: implication of Gli2 and Gli3 as primary mediators of Shh signaling. Development. 1999; 126(17):3915-24. DOI: 10.1242/dev.126.17.3915. View

5.
Uson I, Sheldrick G . Advances in direct methods for protein crystallography. Curr Opin Struct Biol. 1999; 9(5):643-8. DOI: 10.1016/s0959-440x(99)00020-2. View